Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 58 minutes agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 2 hours agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoPfizer Is Aiming To Set The Treatment Standard For Lung Cancer With encouraging results, Pfizer is...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 7 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
The Telegraph via Yahoo News· 6 days agoThe US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 5 days agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which have been on the market since last year. "The FDA...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 3 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Catching cancer early lowers risk of mortality, but screening is the first step
Stacker via AOL· 6 hours agoPfizer funded a $15 million initiative led by the ACS to increase...breast and prostate cancer in...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.